The Future of Rapid Diagnostics: Lessons from SARS-CoV-2 Research By Pratiba Irudayaraj
The following article explores her professional journey, academic focus, and the broader context of the innovative work associated with her name. pratiba irudayaraj fixed
Signal Amplification: Ensuring that even trace amounts of the virus—as low as 50 pg/mL in whole serum—can be detected. Bridging the Gap to Mobile Health The Future of Rapid Diagnostics: Lessons from SARS-CoV-2
Take, for example, her work on [specific initiative or sector—e.g., rural digital literacy / maternal health metrics / legal aid accessibility]. While others pivoted to newer funding trends, Pratiba stayed. She built local feedback loops, trained second-tier leadership, and created maintenance budgets—the boring, essential work that separates pilot projects from permanent change. Three years after her formal role ended, that system still runs at 94% efficiency. While others pivoted to newer funding trends, Pratiba stayed
"Excited to share that our latest research findings on SARS-CoV-2 viral proteins have been finalized and are now published in Frontiers in Virology. After rigorous review, we have fixed the diagnostic parameters to ensure more sensitive detection methods. Check out the full overview here: Link to Research" Option 2: Scientific Community (X/Twitter style)